Portola announces full results of phase 3 APEX study of Betrixaban published
Portola announced full results of its pivotal Phase 3 APEX (Acute Medically Ill VTE Prevention with Extended Duration Betrixaban) Study were published simultaneously online in The New England Journal of Medicine. Portola announced top line results from the APEX trial in March 2016. May 27, 2016